Eric de Montgolfier CEO, Invest Europe
Presentation of the latest data from the EIF from the past 6 months with a look at deal dynamics, the evolution of funding round sizes and price levels. What are the implications for VCs in terms of portfolio management and selection of investment strategy? What changes are needed and which innovations do VCs need to adopt to thrive?
Uli Grabenwarter Deputy Director – Equity Investments, EIF
Dina Chaya Partner, Neomed Management
Staffan Helgesson General Partner, Creandum
Nenad Marovac Founder, Managing Partner, DN Capital
Katya Smirnyagina Executive Director Capricorn Health-tech Fund, Capricorn Partners
A new world of competitiveness is emerging from the crisis. It creates vast opportunities for the daring. How will the economic and business environment influence the strategies of companies and governments? What do companies need to do to thrive? As closing keynote speech, Professor Stephane Garelli, Professor Emeritus at IMD and Founder of the IMD World Competitiveness Center, will look at the changes and challenges of the future and how leaders and companies can react to remain competitive.
Professor Stéphane Garelli Professor Emeritus of World Competitiveness, IMD business school and at the University of Lausanne, Switzerland
Themis Bioscience is a vaccine development company based in Vienna, Austria. Since the outbreak of the Covid-19 pandemic, the company has leveraged their vaccine platform technology to prioritize their work on the development of a vaccine against SARS-CoV-2, the virus strain that causes Covid-19. In this fireside chat, CEO and Founder, Eric Tauber, will discuss the company’s journey from VC-backed start-up to its acquisition by Merck in May 2020, as well as their on-going work in the fight against Covid-19.
Erich Tauber CEO & Founder, Themis Bioscience
Christina Pamberg Managing Partner, Alcyon Holding
Mirakl is the only marketplace SaaS platform that empowers both B2B and B2C organizations to launch and grow an enterprise marketplace at scale. On September 22nd the company announced that it has raised US$300 million at a valuation of over US$1.5 billion led by Permira and with participation from the company’s long term VC investors. In this session, Alexandre Margoline of Permira will chat with CEO Adrien Nussebaum, discussing the Mirakl development to date and the role venture capital support has played, the impact of Covid and the company’s response and the next steps as the company enters a new period of hypergrowth.
Adrien Nussebaum CEO, Mirakl
Alexandre Margoline Partner, Head of Paris, Permira
What is the decision-making process for allocations? What are the unique selling points that differentiate VCs and convince LPs to change allocations?
Marcus Peter Partner, GSK Stockmann
Fidel Manolopoulos Principal, Hermes GPE
Miriam Schmitter Managing Director, Commonfund Capital
Joe Schorge Managing Partner, Isomer Capital
Stephen Lowery Managing Director, Silicon Valley Bank
Greg Revenu Managing Partner, Bryan, Garnier & Co
A panel of leading VCs share their views and experience on managing a crisis and the key factors in ensuring resilience and recovery.
Anne Glover Chief Executive and Co-founder, Amadeus Capital Partners
Regina Hodits Managing Partner, Wellington Partners Life Sciences
Antoine Papiernik Managing Partner, Sofinnova Partners
Carles Ferrer Roqueta General Partner, Nauta Capital
Jan-Gisbert Schultze Founding Partner, Acton Capital
Corporate/CVC investors have become a significant integral part of the entrepreneurial and VC ecosystem, participating in VC-rounds representing 25-50% of total VC investment value and 10-20% of deal-count in Europe, U.S. Israel and APAC. What impact do Corporates/CVC investments have on their portfolio internationalization, growth, deal-size, valuations, exits and deal performance? How does Europe differ from other global innovation hotbeds? What do LPs and GPs need to know on Corporates/CVC participation?
Martin Haemmig Adj. Professor, CeTIM & Global Network Partner, GLORAD
What is the outlook for the next 10 years? How do LPs access new opportunities? What distinguishes the European VC ecosystem? A panel of leading LPs discuss their views and insights.
Eric de Montgolfier CEO, Invest Europe
Thomas Kristensen Principal, LGT Capital Partners
Stanislas Subra Manager of Alternative Investments, MACSF
Stefan Fallgren Senior Investment Manager, Private Equity, Skandia
Natalia Fontecha Managing Director, StepStone
The Founder & CEO of one of Europe's leading tech VCs will provide an update on the state of the European ecosystem and a look to the future.
Klaus Hommels Founder & Chairman, Lakestar
Covid-19 has pushed us all to operate virtually, to an extent unimaginable before now. Join this interactive roundtable to learn more about recent fund manager experiences of committing to new investments and fundraising entirely virtually and to discuss the implications for the future.
Max Bautin Managing Partner, IQ Capital
Haakon Overli Co-Founder & General Partner, Dawn Capital
An open discussion on recent trends, impact of Covid-19 on fundraising and the outlook going forward.
Anna Serafini Head of Private Equity & Venture Capital, Sabadell Asset Management a company of Amundi
Jörg Goschin Co-CEO and Senior Managing Director, KfW Capital
Ian Connatty Managing Director, British Patient Capital
What are the key factors in successful succession planning? Where are the pitfalls? What are is the LP perspective on succession planning and what are their expectations?
Till Burges Managing Director, HarbourVest Partners
Xavier Lazarus Partner, Elaia
Christina Brinck Investment Director, AP6
Björn Odlander Founding Partner, Healthcap
William van Eesteren Managing Director, Wilshire Private Markets
Most PCs automatically accept them but you can change your browser settings to restrict, block or delete cookies if you want. Each browser is different, so check the 'Help' menu of your particular browser (or your mobile phone's handset manual) to learn how to change your cookie preferences. Many browsers have universal privacy settings for you to choose from.
Cookie settings in most versions of Internet Explorer can be found by clicking the tools option and then the privacy tab.
Cookie settings in Firefox are managed in the Options window's Privacy panel. See Options window - Privacy Panel for information on these settings.
Click on the spanner icon on the toolbar, select settings, click the under the bonnet tab, click on content settings in the privacy section.
You can manage cookies in Opera if you Click on settings, then Preferences, then Advanced and finally Cookies
Choose Safari, then preferences and then click security. You should then be able to specify if and when Safari should accept cookies.
To manage cookies on your mobile phone please consult your manual or handbook.
If you decline cookies, some aspects of Invest Europe site may not work on your computer or mobile phone and you may not be able to access areas you want on the website. For this reason we recommend that you accept cookies.
If you delete all your cookies you will have to update your preferences with us again and some aspects of our site may not work.
If you use a different device, computer profile or browser you will have to tell us your preferences again.
If you'd like to learn more about cookies in general and how to manage them, visit aboutcookies.org.
We can't be responsible for the content of external websites.Opt-out of cookies